Varadarajulu Shyam, Wilcox C Mel
Division of Gastroenterology-Hepatology, University of Alabama at Birmingham School of Medicine, Birmingham, AL 35294-0007, USA.
J Pediatr Gastroenterol Nutr. 2006 May;42(5):526-30. doi: 10.1097/01.mpg.0000221891.21254.a2.
Data on sphincter of Oddi dysfunction (SOD) in children are scant. Most children diagnosed with SOD are treated by biliary sphincterotomy with suboptimal results. The efficacy and safety of pancreatic and dual sphincterotomy in children with SOD has not been previously reported.
To evaluate the efficacy and safety of pancreatic and dual sphincterotomy in children with SOD.
Prospective evaluation of all children who underwent endoscopic retrograde cholangiopancreatogram (ERCP) with sphincter of Oddi manometry for evaluation of suspected SOD over a 3-year period. Children diagnosed with SOD underwent pancreatic or dual sphincterotomy with prophylactic pancreatic stenting.
SOD was diagnosed by sphincter of Oddi manometry in 6 of 11 children who underwent ERCP for suspected SOD. Of the 6 children (mean age, 11 years; range, 5-16; 4 girls) with SOD, 3 presented with recurrent pancreatitis and 3 with postcholecystectomy pain. Pancreatic sphincter hypertension was noted in all 6 patients; concomitant biliary sphincter hypertension was noted in 3 patients with postcholecystectomy pain. Patients with recurrent pancreatitis underwent pancreatic sphincterotomy and those with postcholecystectomy pain underwent dual sphincterotomy. Prophylactic pancreatic stents were placed in all patients. One girl experienced mild post-ERCP pancreatitis. At a mean follow-up of 583 days (range, 325-1445), 4 patients were asymptomatic, 1 experienced partial symptom relief and 1 had recurrent symptoms.
As in adults, pancreatic and dual sphincterotomy, in expert hands, is effective and safe in a subgroup of children with SOD. Prospective, randomized trials with larger number of patients are required to validate the efficacy of endotherapy in children with SOD.
关于儿童Oddi括约肌功能障碍(SOD)的数据很少。大多数被诊断为SOD的儿童接受胆管括约肌切开术治疗,但效果欠佳。此前尚未报道过胰腺括约肌切开术和双括约肌切开术治疗儿童SOD的疗效和安全性。
评估胰腺括约肌切开术和双括约肌切开术治疗儿童SOD的疗效和安全性。
对3年内所有因疑似SOD接受内镜逆行胰胆管造影(ERCP)及Oddi括约肌测压的儿童进行前瞻性评估。被诊断为SOD的儿童接受胰腺或双括约肌切开术并预防性置入胰腺支架。
在11例因疑似SOD接受ERCP的儿童中,6例经Oddi括约肌测压诊断为SOD。在这6例SOD患儿中(平均年龄11岁,范围5 - 16岁;4名女孩),3例表现为复发性胰腺炎,3例表现为胆囊切除术后疼痛。所有6例患者均存在胰腺括约肌高压;3例胆囊切除术后疼痛患者同时存在胆管括约肌高压。复发性胰腺炎患者接受胰腺括约肌切开术,胆囊切除术后疼痛患者接受双括约肌切开术。所有患者均预防性置入胰腺支架。1名女孩出现轻度ERCP术后胰腺炎。平均随访583天(范围325 - 1445天),4例患者无症状,1例症状部分缓解,1例症状复发。
与成人一样,在专家手中,胰腺和双括约肌切开术对一部分儿童SOD患者有效且安全。需要进行有更多患者参与的前瞻性随机试验来验证内镜治疗儿童SOD的疗效。